MedEdge Home   

MedEdge Products

MedEdge Eyewear Sale

MedEdge Clinical Papers

About MedEdge

Contact MedEdge


            

 

Introduction

Video Gallery

Before & After Photos

Clinical Studies

Certification

FAQ


Introducing the CryoShape™ Cool Solution for Keliod Scars

Developed by a plastic surgeon, CryoShape™ is a breakthrough hand-held cryosurgical instrument for destroying deep tissue through intralesional intervention utilizing an extremely cold cryoprobe.  The CryoShape™ probe effectively treats Keloids and Hypertrophic Scars via direct treatment of the deep scar material as well as an increased freezing area along the entire scar.

Unlike other procedures, CryoShape™ requires only one session to significantly reduce scar volume - with minimal discomfort and recovery and no pigmentation changes of the surrounding skin. CryoShape™ is a patented intralesional double lumen probe for treating Keloid and Hypertrophic Scars. The CryoShape™ device is a hand-held cryosurgical instrument for destroying deep tissue through intralesional intervention utilizing an extremely cold probe. The elegant CryoShape™ probe effectively treats Keloid and Hypertrophic Scars via a direct thermal effect on the deep scar material as well as causing softening and normalization of collagen within and surrounding the scar.

CryoShape™ requires only one single session to significantly reduce scar volume. Quick alleviation of pruritus, pain, discomfort, and tenderness means patients can leave the office same day with little recovery time. The single-needle insertion procedure is simple to perform, performed using a local anesthetic, allows minimal pigmentation changes, and virtually no risk of worsening the scar. In more than 97% of the cases performed, no scar recurrence was observed.

In contrast, other treatment options require several treatments over a prolonged time with modest success rates (pressure therapy and topical applications of silicones, gels and other adhesives), present risk of skin atrophy and scar depression (corticosteroid injections), or extremely high risk of recurrence (surgical excisions). A scientific comparison between CryoShape™ results and those of contact cryosurgery clearly demonstrates the superiority of the CryoShape™ for treating the scar at the origin and sparing of the uninvolved surrounding skin.

The CryoShape™ device and procedure have been designed for physician simplicity as well as maximum patient effectiveness. The freezing temperature generated by CryoShape™ is skin friendly, penetrating and affecting only the scar area sparing normal uninvolved tissue. The CryoShape™ technique freezes the scars from the inside, thus providing penetration to deep scar tissue, in order to block further blood circulation in the unwanted tissue. While performing CryoShape, the targeted area is easily anesthetized, allowing the physician to perform the brief procedure without discomfort to the patient - including after the treatment. Post treatment wound care is very simple, the patient may resume full activity, including return to work, the following day.

No sutures are involved in the procedure and the targeted area is easily anesthetized, making the treatment virtually painless for the patient.


CryoShape™ probe

What is needed to perform the procedure?

  • CryoShape™ probe
  • CryoPro™ pressurized canister (2 are recommend for uninterrupted treatment)
  • Source of liquid nitrogen
CryoShape™ is designed for use in the treatment of keloid and hypertrophic scars in order to achieve optimal results. Efficacy is achieved due to:
  • Direct treatment of the deep scar material.
  • The increased freezing area, along the whole extent of the scar.
  • Clear Advantages Over Other Treatments:
  • Significant reduction in scar volume after one treatment.
  • Most cases require only a single session.
  • Quick alleviation of pruritus, pain, discomfort and tenderness.
  • Minimal or no hypopigmentation or other side effects.
  • The procedure consists of a single needle insertion (excluding local anesthetic), allowing the patient to leave the clinic immediately following the treatment.
  • Large scars can also be treated using the CryoShape.
  • Multiple scars may be treated in a single session.
  • Rapid healing process; minimal postoperative care is required.
  • In most cases (>97%) no scar recurrence is observed.
  • Clinically no worsening of scar has been observed.
Other treatment options require several treatments over a prolonged time with modest success rates (pressure therapy and topical applications of silicones, gels and other adhesives), present risk of skin atrophy and scar depression (corticosteroid injections), or extremely high risk of recurrence (surgical excisions). A comparison of CryoShape™ outcomes and those of contact cryo-surgery clearly demonstrates the superiority of CryoShape™ as treating the scar at the origin. CryoShape™ is an effective choice to treat Keloid and Hypertrophic Scars at virtually every location on the body.

 

TOP OF PAGE


CryoShape™ Video Gallery

TOP OF PAGE






CryoPro™ pressurized canister









CryoShape™ Before and After Photos

 

TOP OF PAGE


CryoShape™ Clinical Studies

Keloid and Hypertrophic Scars are raised progressive scars, characterized by being voluminous, and occasionally erythematous. The patient may remain asymptomatic or experience pain and/or pruritis. Depending on location, the lesion is frequently accompanied by psychological ramifications of discomfort and disfigurement. Until now, there has been no clinically effective therapy (surgical or nonsurgical) to remove keloid and hypertrophic scars.

The CryoShape methodology signifies a novel and efficacious therapeutic advance in this field of therapeutics. One minor in-office procedure in the majority of cases will suffice to eliminate the keloid.

Several clinical studies clearly demonstrated the efficacy of the CryoShape due to its rapid and effective freezing of the deep scar.

Clinical data and patient follow-up have confirmed dramatic results from CryoShape treatment for keloid and hypertrophic scar removal, far surpassing traditional methods including intralesional steroid injections, laser resurfacing, excisional surgery, radiation therapy, topical agents, and pressure therapy. CryoShape typically requires only a single treatment session, with almost immediate alleviation of itching, pain, and tenderness. Even more compelling, CryoShape has been designed to eliminate or dramatically minimize any recurrence of raised or thickened scars.

Clinical results have demonstrated over 93% of patients treated with CryoShape have shown significant improvement and long-term results. An average of about 60% of scar volume reduction was achieved following a single treatment session. The CryoShape treatment preserved the original skin color with no hypo-pigmentation in 87% of the cases.

The clinical results clearly show significant improvement in quality of life:

  • Pruritus and discomfort reduced by 55%

  • Pain and tenderness was decreased by 75%

  • Hardness decreased by an average of 67%

  • Erythema decreased by 50%


J Eur Acad Dermatol Venereol. 2011 Sep;25(9):1027-36. doi: 10.1111/j.1468-3083.2010.03911.x. Epub 2010 Nov 25.

Keloid histopathology after intralesional cryosurgery treatment.
Har-Shai Y, Mettanes I, Zilberstein Y, Genin O, Spector I, Pines M.

Source:

Department of Plastic Surgery, The Bruce Rappaport Faculty of Medicine, Carmel Center, Technion-Israel.

Abstract:

Background:

Keloid presents a great healthcare challenge. The patients suffer from aesthetic disfiguration and occasionally from pruritus, pain and discomfort. Although various treatments are recommended, a single, highly effective treatment represents a great clinical need.

Objective:

The cellular events and histopathology that follow intralesional cryosurgery were evaluated including cell proliferation, the number of cells expressing fibroblast markers, collagen synthesis and organization and mast cell infiltration.

Methods:

Biopsies were collected before and after intralesional cryoneedle procedure. Collagen structure was evaluated with confocal microscopy. Mast cells, blood vessels and cell proliferation were evaluated using immunohistochemistry.  

Results:

Keloids contain abnormally thick collagen bundles, organized in swirls comprising closely bound fibrils. After intralesional cryosurgery, the collagen bundles lost their swirl structure, the thickness of the collagen layer decreased, and the bundles became more compact with less space between the fibres. A clear distinct transition zone separated the treated from the unaffected area. The frozen tissue was devoid of proliferating cells and mast cells whereas the number of blood vessels remained unaltered. Most of the fibroblasts expressed all tested myofibroblast markers although some exclusively expressed one and not the other. Few nuclei were observed in the affected area after treatment and very few of them expressed any fibroblast markers.

Conclusions:

Intralesional cryosurgery resulted in major changes in collagen structure and organization. The treatment reduced the number of proliferating cells, of myofibroblasts and of mast cells. These results may explain the reduction in no-response rate and the amelioration of the clinical symptoms after intralesional cryosurgery treatment.
Journal of the European Academy of Dermatology and Venereology ©2010 European Academy of Dermatology and Venereology. No claim to original US government works.

PMID: 21108665

[PubMed - indexed for MEDLINE]


Int J Low Extrem Wounds. 2008 Sep;7(3):169-75.

Intralesional cryosurgery for the treatment of hypertrophic scars and keloids following aesthetic surgery: the results of a prospective observational study.

Har-Shai Y, Brown W, Labbé D, Dompmartin A, Goldine I, Gil T, Mettanes I, Pallua N.

Source:

The Bruce Rappaport Faculty of Medicine, Unit of Plastic Surgery, Carmel Medical Center, Israel Institute of Technology, Technion, Haifa, Israel. yaron07@yahoo.com

Abstract:

Hypertrophic scars and keloids following aesthetic surgery, which ignite patient dissatisfaction, are difficult to handle. Intralesional cryosurgery for the treatment of such scars has been introduced. This study was designed to evaluate the efficacy of this technology in the treatment of such scars and to assess the reduction of dissatisfaction. Eleven scars (on 11 patients) were treated by intralesional cryosurgery, following breast surgery, otoplasty, facelifting, and brachioplasty. Each patient scored the concern from the scar and the scar deformity (scale from 1 to 5) prior and following treatment (higher score represents least satisfaction and a severe deformity). The follow-up period was between 3 months and 8 years. The results demonstrated a significant reduction in concern and deformity scores compared with before the cryotreatment (P = .001). The intralesional cryosurgery technique provides the plastic surgeon with an effective instrument to treat hypertrophic scars and keloids following aesthetic surgery, thus reducing the dissatisfaction of patients.


Plast Reconstr Surg. 2003 May;111(6):1841-52.

Intralesional cryosurgery for the treatment of hypertrophic scars and keloids following aesthetic surgery: the results of a prospective observational study.

Har-Shai Y, Brown W, Labbé D, Dompmartin A, Goldine I, Gil T, Mettanes I, Pallua N

Source

The Bruce Rappaport Faculty of Medicine, Unit of Plastic Surgery, Carmel Medical Center, Israel Institute of Technology, Technion, Haifa, Israel. yaron07@yahoo.com

Abstract

Hypertrophic scars and keloids following aesthetic surgery, which ignite patient dissatisfaction, are difficult to handle. Intralesional cryosurgery for the treatment of such scars has been introduced. This study was designed to evaluate the efficacy of this technology in the treatment of such scars and to assess the reduction of dissatisfaction. Eleven scars (on 11 patients) were treated by intralesional cryosurgery, following breast surgery, otoplasty, facelifting, and brachioplasty. Each patient scored the concern from the scar and the scar deformity (scale from 1 to 5) prior and following treatment (higher score represents least satisfaction and a severe deformity). The follow-up period was between 3 months and 8 years. The results demonstrated a significant reduction in concern and deformity scores compared with before the cryotreatment (P = .001). The intralesional cryosurgery technique provides the plastic surgeon with an effective instrument to treat hypertrophic scars and keloids following aesthetic surgery, thus reducing the dissatisfaction of patients.

PMID:18757392
[PubMed - indexed for MEDLINE]

http://www.ncbi.nlm.nih.gov/pubmed/12711943
 


Plast Reconstr Surg. 2003 May;111(6):1841-52.

Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids.
Har-Shai Y, Amar M, Sabo E  

Source:

Unit of Plastic Surgery and Department of Pathology, Carmel Medical Center, Haifa, Israel. yaron07@yahoo.com

Abstract:

Although therapeutic management of hypertrophic scars and keloids using contact or spray cryosurgery has yielded significant improvement or complete regression of hypertrophic scars and keloids, it requires one to 20 treatment sessions. This study was designed to assess the clinical safety and efficacy of an intralesional needle cryoprobe method in the treatment of hypertrophic scars and keloids. Ten patients, ranging in age from 3 to 54 years, with a total of 12 hypertrophic scars and keloids of more than 6 months duration and of diverse causes, were included in this study. The 18-month trial evaluated volume reduction of the hypertrophic scars and keloids after a single session of intralesional cryotherapy. Objective (hardness and color) and subjective (pain/tenderness and itchiness/discomfort) parameters were examined on a scale of 0 to 3 (low score was better). Pretreatment and posttreatment histomorphometric studies of the collagen fibers included spectral picrosirius red polarization and fast Fourier transformation orientation index. A specially designed cryo-needle was inserted into the long axis of the hypertrophic scars and keloids so as to maximize the volume of the hypertrophic scars and keloids to be frozen. The cryo-needle was connected by an adaptor to a cryogun filled with liquid nitrogen, which was introduced into the cryoprobe, thereby freezing the hypertrophic scars and keloids. After the hypertrophic scars and keloids were completely frozen, the cryoprobe defrosted and was withdrawn. An average of 51.4 percent of scar volume reduction was achieved after one session of intralesional cryosurgery treatment (average preoperative hypertrophic scars and keloids volume, 1.82 +/- 0.33; average posttreatment volume, 0.95 +/- 0.21; p < 0.0022). Significant alleviation of objective and subjective clinical symptoms was documented. Mild pain or discomfort during and after the procedure was easily managed. Only mild local edema and epidermolysis, followed by a short reepithelialization period, were evident. During the 18-month follow-up period, there was no evidence of bleeding, infection, adverse effects, recurrence, or permanent depigmentation. The histomorphometric analysis demonstrated rejuvenation of the treated scars (i.e., parallelization) and a more organized architecture of the collagen fibers compared with the pretreated scars. This study demonstrated the increased efficacy of this method as a result of increased freezing area of deep scar material compared with that obtained with contact/spray probes. As a result, fewer treatment cycles are needed. Because the reepithelialization period is short, treatment intervals, if any, can be shortened to 2 to 3 weeks. This intralesional cryoneedle method is simple to operate and safe to use, it necessitates less postoperative care of the wound, and it can easily be added to any preexisting cryosurgical unit.

PMID:12711943 [PubMed - indexed for MEDLINE]

PMID: 21108665 [PubMed - indexed for MEDLINE]

TOP OF PAGE










 

FAQ

Is CryoShape safe for darker skin types?
CryoShape is safe for all skin types, from Type I through Type VI.

How many CryoShape treatments will I need?
Unlike other procedures, CryoShape requires only one single session to significantly reduce scar volume. Quick alleviation of tenderness, itching, discomfort means that patients can leave the office same day with little recovery time. Even large keloid and hypertrophic scars may be treated with CryoShape.

What are the risks associated with CryoShape?
The single-needle insertion procedure is simple to perform in your doctor's office using a local anesthetic. There are minimal if any pigmentation changes, and virtually no risk of worsening the scar.

Will my scar come back after CryoShape treatment?
In over 97% of the cases performed to date, no scar recurrence was observed. Most patients require only a single procedure to significantly reduce the size and shape of keloid or hypertrophic scars.

Are there any side effects with CryoShape?
Most patients have few side effects, and minimal discomfort. Skin pigment changes are rare when using CryoShape.

Does the treatment hurt?
No sutures are involved in the procedure and the targeted area is easily anesthetized, making the treatment virtually painless for the patient. Treatment takes from 10 minutes to an hour depending on scar volume. Patients can leave their doctor's office immediately following treatment.

When can I go back to work or school after CryoShape?
Post treatment wound care is very simple, and patients may resume full activity, including return to work, the following day, or even the same day if desired. The healing process is very rapid after CryoShape and simply involves local wound care.

Can CryoShape be used on children?
CryoShape has been demonstrated to be safe to use on children.

Who can perform the CryoShape procedure?
Only a licensed and certified physician is able to use the CryoShape device, and the procedure is only available to be performed in a doctor's office.

TOP OF PAGE
 





 

MedEdge Events

MedEdge Careers

MedEdge, Inc.         

A Value-Added Distributor of Emerging Aesthetic Technologies

MedEdge, Inc.
PO Box 3028
Venice, CA 90294

Phone:
Fax:
Mobile:
(310) 392-9843
(310) 581-1972
(310) 562-3966
Email:

 

Home      Products      Clinical      About     Contact     Events     Careers

Copyright  ©  2003 - 2013  MedEdge, Inc.